Three clocks are running; only one is on your calendar. The egg clock is fastest, a bending curve, not a plateau: monthly odds of conceiving fall from about 1 in 4 in the early 20s to 1 in 20 at 40, and miscarriage passes half by 45 1 2. The sperm clock is slower but real: men over 45 are twelve times more likely to take over two years 3. The first-trimester clock is tightest: the neural tube closes by day 28, before most positive tests, so folate, alcohol, and risky drugs get sorted the month before conception 4.
The methods gap is just as wide. The pill in real life fails about 7 to 9 in 100 women a year; the implant and both IUDs fail under 1 in 100 5. Given free choice, women on the long-acting ones had unintended pregnancies fall about twentyfold 6. And folate before conception prevents about half of first-occurrence neural tube defects 4.
Both tails are common. Almost half of US pregnancies start unintended, and that cohort carries double the postpartum-depression risk 7 8. And one in four American female physicians who wanted children reach menopause without them, from trying too late 9.
The whole plan is four questions, re-answered at every inflection — a new relationship, age 30, age 35. The answer sets the action 10.
Already trying? See a clinician after 12 months under 35, 6 months at 35+, right away at 40+ 13.
What settles, and when.
- Within a month or two: on a method that fails under 1% a year, the calendar-watching quiets.
- Within a year: if you were trying, the pregnancy is intended and folate was in place, so postpartum-depression risk sits at baseline 8.
- Over the decade: the decision got made on purpose, in the ages your body still favoured.
The fine print — when to skip it, and what people get wrong
"An AMH test tells me my fertility." No — low AMH doesn't predict lower natural-conception odds; it's a marketing hook the evidence doesn't back 14 15. "Egg freezing is insurance." It's a hedge: live birth per patient is about 52% from eggs banked by 35, about 19% from 40+ 12.
Method mismatches matter. Estrogen-containing pill, patch, and ring are unsafe with smoking over 35, migraine with aura, uncontrolled hypertension, or a clot history; progestin-only methods and IUDs stay open. Never stop an SSRI or anti-epileptic cold to "be safe" — that's a clinician's switch to make 4.
Where the plan breaks. Made once at 22 and never revisited; budgeted against a vague "late 30s is fine" instead of the curve; a pill left running for a decade-long "not yet"; folate started after the positive test, too late for day 28 4.
- 1ASRM (2014). Female age-related fertility decline. Committee Opinion No. 589. Fertility and Sterility. link
- 2Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M (2000). Maternal age and fetal loss: population based register linkage study. BMJ. link
- 3Hassan MAM, Killick SR (2003). Effect of male age on fertility: evidence for the decline in male fertility with increasing age. Fertility and Sterility. link
- 4USPSTF (2023). Folic acid supplementation to prevent neural tube defects: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. link
- 5Trussell J, Aiken ARA, Micks E, Guthrie KA (2018). Efficacy, safety, and personal considerations. In: Contraceptive Technology, 21st ed. link
- 6Winner B, Peipert JF, Zhao Q, et al. (2012). Effectiveness of long-acting reversible contraception. New England Journal of Medicine. link
- 7Finer LB, Zolna MR (2016). Declines in unintended pregnancy in the United States, 2008–2011. New England Journal of Medicine. link
- 8Qiu X, Zhang S, Sun X, et al. (2020). Unintended pregnancy and postpartum depression: a meta-analysis of cohort and case-control studies. Journal of Psychosomatic Research. link
- 9Stentz NC, Griffith KA, Perkins E, Jones RD, Jagsi R (2016). Fertility and childbearing among American female physicians. Journal of Women's Health. link
- 10CDC, OPA (2014). Providing quality family planning services: recommendations of CDC and the U.S. Office of Population Affairs. MMWR Recommendations and Reports 63(RR-4). link
- 11AUA (2024). Vasectomy: AUA Guideline (amended 2024). link
- 12ASRM (2021). Evidence-based outcomes after oocyte cryopreservation for donor oocyte IVF and planned oocyte cryopreservation: a guideline. Fertility and Sterility. link
- 13ASRM (2021). Fertility evaluation of infertile women: a committee opinion. Fertility and Sterility. link
- 14Steiner AZ, Pritchard D, Stanczyk FZ, et al. (2017). Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA. link
- 15Hu KL, Liu FT, Xu H, Li R, Qiao J (2020). The value of anti-Müllerian hormone in the prediction of spontaneous pregnancy: a systematic review and meta-analysis. Frontiers in Endocrinology. link
Reproductive Life Planning
The plan itself is free. LARC insertion is typically $0–$50 in the US under ACA coverage; folic acid is under $20/year; vasectomy is ~$500–$1,000 one-time. The outlier is elective egg freezing ($10,000–$15,000/cycle plus storage), which is optional and only applies to a subset. Default cost is trivial.
A 10-minute conversation revisited at life inflections; downstream actions are one-time (LARC insertion, vasectomy) or low-burden (one folate pill daily during a preconception window). Mild lifestyle shift at most for the preconception runway.
Component actions are settled: LARC reduces unintended pregnancy ~20-fold vs. pill/patch/ring (Winner et al. NEJM 2012); folic acid reduces NTD recurrence 72% in placebo-controlled RCT (MRC 1991); the age-fecundability and age-aneuploidy curves are population-level facts (Andersen et al. BMJ 2000; ASRM 2014; Frederiksen et al. 2024). The planning conversation itself has moderate direct evidence — CDC 2014 acknowledges the limited RCT base for the planning act per se — but the chain of component actions it enables is high-evidence. Overall 4.
Two convergent mood signals: (1) unintended pregnancy roughly doubles postpartum depression risk (Qiu et al. 2020 meta-analysis, OR 1.55–2.0 across pooled cohorts), so planning that prevents unintended pregnancies reduces a substantial depressive-episode exposure; (2) reaching menopause without one's stated family size is associated with measurable regret and grief in cohort studies (Stentz et al. 2016 in physicians). Planning addresses both tails. Clear stabilisation rather than transformative — 3.
Two real but additive contributions: (1) age-matched attempt timing lowers exposure to advanced-maternal-age maternal morbidity and mortality (preeclampsia, severe maternal morbidity, gestational complications; ACOG Obstetric Care Consensus #11, 2022); (2) high-tier contraception lowers unintended-pregnancy mortality and morbidity exposure (Winner et al. NEJM 2012). Neither is a dominant longevity lever; in aggregate a 2.
The planning act itself is not felt-better-in-weeks. Downstream actions can produce small short-term wins: relief from contraceptive uncertainty after LARC placement, glycaemic and BMI optimisation during the preconception runway (CDC 2006). Honest score: 1.
Removing the background cognitive load of unresolved reproductive uncertainty has a small attentional payoff for some readers, particularly women in their 30s with no plan. No direct cognitive-performance trial evidence; mechanism plausible. Conservative 1.